Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06476899
PHASE2
A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy
Sponsor: Fei Li
View on ClinicalTrials.gov
Summary
Prospective, interventional, and practical clinical studies
Official title: A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy in Previously Untreated CLL/SLL
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-07-24
Completion Date
2026-12-26
Last Updated
2024-06-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
orelabrutinib
orelabrutinib tablets
DRUG
FCR/BR
FCR/BR
DRUG
BTK inhibitor
BTK inhibitor choose by physican